AI Terminal
Biohit Oyj
AGM Information • Apr 25, 2019
3304_rns_2019-04-25_447befe1-c942-41ae-b1c4-35ca0ef34410.html
AGM Information
Open in ViewerOpens in native device viewer
Constitutive meeting of Biohit Oyj’s Board of Directors
Constitutive meeting of Biohit Oyj’s Board of Directors
Biohit Oyj: Other information disclosed according to the rules of the Exchange April 25, 2019 at 9:30 am local time (EEST)
Biohit Oyj’s Board of Directors has in its meeting yesterday elected Mr Osmo Suovaniemi as the Chairman of the Board of Directors.
Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group.